Campylobacter Coli

If you have watery or bloody diarrhea for more than a couple of days, this test can identify a common bacterial cause faster than stool culture. It looks for bacterial DNA in stool, so it can catch infections that culture misses when the organism dies in transit or fails to grow.

In one multisite study, culture missed 28% of true-positive specimens and had a 30% false-result rate compared with immunoassay and molecular methods. A negative culture doesn't always close the case.

What This Test Actually Measures

Nothing in your body makes this. Campylobacter coli is a bacterium you pick up from the outside world, usually from undercooked chicken or pork, unpasteurized milk, untreated water, or contact with animals. The test amplifies fragments of the bacterium's own DNA out of your stool.

The method is qPCR, short for quantitative polymerase chain reaction. It copies a specific stretch of bacterial DNA over and over until there is enough to detect. Fewer copying cycles usually means more bacterial DNA was in the sample to begin with. Some labs can see this value as a cycle threshold, or Ct. Many patient reports only say detected or not detected.

Which stretch of DNA the lab targets matters. Assays aimed at the ceuE gene can tell C. coli apart from C. jejuni, agreeing with culture about 95.7% of the time in one study. Older assays built around cadF can miss infections when the target sequence varies. A newer rpsK/rpsD target found 23% more C. jejuni and C. coli infections than the cadF version in stool samples checked against sequencing.

One caveat runs through almost all the evidence below. Many studies and many commercial panels measure C. jejuni and C. coli together. When the evidence uses that combined stool DNA target, the lesson applies to the combined result, not a perfectly isolated C. coli signal.

Acute Gastroenteritis

Campylobacter species are among the leading causes of bacterial diarrhea and dysentery worldwide. C. jejuni causes most human cases, with C. coli next in line. A heavy load in stool usually means active infection: watery diarrhea, fever, cramping, and in more invasive cases visible blood.

Bloody diarrhea is the strongest clinical clue. In a study of hospitalized adults with acute diarrhea, people with blood in the stool were about ten times as likely to have a positive stool PCR result as those without it. If you are seeing blood, the odds that a molecular test finds a bacterial cause go up sharply.

The bacterium can break through the lining of the intestine. That draws immune cells into the gut wall, which is why infection can travel with higher stool inflammation markers such as lactoferrin, calprotectin, and myeloperoxidase. Those markers support the story. They do not replace the organism-specific result.

When Infection Turns Invasive

Most cases stay in the gut and resolve on their own. Some do not. Among hospitalized adults, severe Campylobacter infection has been linked to systemic complications, including bacteremia, where the organism gets into the bloodstream.

Two pooled analyses of Campylobacter bloodstream infections found meaningful mortality and relapse risk, concentrated in older and immunocompromised people, along with high rates of antibiotic resistance. This is why a fast, specific answer can matter more than waiting out a bad week.

If your immune system does not make antibodies normally, the calculus changes. In one prospective cohort of 73 adults with hypogammaglobulinemia receiving antibody replacement therapy, Campylobacter was found in 15.1% of patients, and positive patients had more diarrhea and higher stool calprotectin. Case literature also links antibody deficiency to recurrent or severe infection, including bloodstream infection, endocarditis, and osteomyelitis. In that group, a sensitive stool test can change how hard you look for persistence.

Long-Term Consequences After a Severe Bout

A single episode of bacterial gastroenteritis can leave a mark years later. After a drinking-water contamination outbreak, a study followed 1,977 adults for about eight years. Those who had acute gastroenteritis during the outbreak went on to have higher rates of high blood pressure, kidney impairment, and self-reported cardiovascular disease than those who did not get sick.

The outbreak involved both E. coli O157:H7 and Campylobacter, so the finding does not isolate this one species. It still argues against treating a severe bout as a week you simply get through. It is a reason to document what you had, treat severe disease properly, and check blood pressure and kidney function afterward.

Children and Growth

In low-resource settings, repeated Campylobacter exposure in early childhood has been linked to poorer growth and gut inflammation. In a cohort of 1,715 children followed to age two, cumulative C. jejuni/coli infection was associated with lower length-for-age at 24 months and higher stool myeloperoxidase. Myeloperoxidase is a marker of gut inflammation.

Some studies also connect high Campylobacter burden with environmental enteric dysfunction. In that condition, long-running gut inflammation can blunt nutrient absorption. An Ethiopian cross-sectional study found high Campylobacter diversity and microbiome patterns tied to gut permeability and inflammation, but it did not prove that this one species caused the condition.

Quantitative testing is what made much of this visible. When researchers reapplied molecular methods to a large multi-country pediatric study, the share of childhood diarrhea attributable to C. jejuni or C. coli roughly doubled compared with culture and antigen testing.

Why a Positive Result Is Not Automatically Your Answer

qPCR detects DNA. DNA does not have to come from a live, actively infecting organism. It can show up in people carrying the bacterium without symptoms, and it can linger after an infection has cleared.

One cohort tracked shedding after diagnosis and found DNA still detectable for a median of 42 days, while viable organisms recoverable by culture lasted a median of 29 days. Almost a third of people were still PCR-positive more than six weeks out, while feeling fine. In a Norwegian study of asymptomatic adults, Campylobacter was one of the pathogens found in people with no illness.

That is why the cycle threshold matters when the lab can provide it. Stools that also grow the organism in culture carry substantially more bacterial DNA than stools that are PCR-positive but culture-negative. In pediatric work, a quantitative cutoff separated diarrheal illness from incidental detection better than a simple yes-or-no result. A low cycle number with active symptoms points to real infection. A high cycle number in someone who feels well points more toward residual DNA or carriage.

Reconciling the Two Halves

This marker does not work like a cholesterol number. It is a detection test whose meaning depends on two things the number alone cannot tell you: how much bacterial DNA is present, and whether you are currently sick. Plenty of bacterial DNA plus active diarrhea is an infection. A trace of DNA six weeks after you recovered is a footprint. The lab may report the same word, positive, for both.

How This Compares to a Stool Culture

The performance gap is wide and consistent. Across multi-center trials, PCR panels detect C. jejuni and C. coli with sensitivity in the 92% to 100% range and specificity above 98%. In a 4,242-sample evaluation of one commercial panel, molecular testing agreed with the reference standard 97.5% of the time on positives and 99.0% on negatives. Other platforms have also reported very high sensitivity in clinical cohorts.

Culture struggles for a biological reason. Campylobacter needs low-oxygen conditions to grow and dies off quickly in transit or after freezing. Reported false-negative rates for culture run from about 28% in clinical studies to much higher in field studies with hard-to-handle samples. Culture also takes two to four days; qPCR can return a result in hours, and some syndromic panels run in about 80 minutes.

Rapid antigen tests sit in a worse position. They look for bacterial proteins rather than DNA, and in a multicenter evaluation three of four commercial antigen tests had positive predictive values between 41% and 57% after PCR resolution. A positive antigen result can be weak evidence in low-prevalence settings, which is why antigen tests should not be used as standalone tests.

If your stool culture came back negative and your symptoms have not resolved, that negative does not close the question. Molecular testing is the next step, not a repeat of the same question.

The One Thing PCR Cannot Do

It cannot tell you which antibiotics will work. Susceptibility testing requires growing the actual organism, so reflex culture on a PCR-positive sample remains standard practice when resistance could change treatment. Among men who have sex with men presenting with proctitis or enteritis, sexually transmitted Campylobacter has shown high rates of multidrug resistance, which makes recovering a live isolate useful.

Retesting and What a Trend Means Here

This is not a marker you track annually. It is a test you order when something is wrong. Serial testing has a real role, but repeating it too soon often produces a positive result that tells you little.

Given a median of 42 days of DNA shedding, a follow-up test two or three weeks after treatment can come back positive whether or not you still have an infection. If your symptoms have resolved and you are not high risk, that positive is usually a footprint. Skip the retest and trust how you feel.

Retesting is worth doing in two situations. If symptoms persist or come back after treatment, repeat the test alongside a culture so you can get susceptibility results and find out whether you are dealing with a resistant organism or a different problem. If you have an antibody deficiency, serial monitoring can be reasonable because persistent carriage in that setting is common and carries more risk.

What to Do With an Unexpected Result

A positive result with active diarrhea calls for two things: a reflex culture for susceptibility testing, and stool inflammation markers such as calprotectin or lactoferrin to confirm that the gut lining is inflamed. Low inflammation markers alongside a weak signal argue for carriage rather than infection.

A positive result with no symptoms is the situation most likely to lead you astray. Check when you were last ill. If you had gastroenteritis in the past six weeks, residual DNA is the most likely explanation, and treating it is more likely to expose you to antibiotic side effects than to help. If you have never had symptoms and this turned up on a broad panel, the cycle threshold and inflammation markers matter more than the positive flag.

Some patterns warrant a specialist. Recurrent or persistent infection, especially with any history of frequent infections elsewhere, is a reason to involve an immunologist and check immunoglobulin levels: persistent Campylobacter is a recognized presentation of antibody deficiency. Diarrhea that continues after the organism is cleared, or a positive result in the middle of an inflammatory bowel disease flare, belongs with a gastroenterologist. In outpatients with IBD relapse, molecular panels detected more pathogens and changed management, but they did not improve disease outcomes, so a positive finding there needs careful interpretation.

Fever with signs of systemic illness rather than gut symptoms alone should prompt blood cultures, not more stool testing. That is the pathway toward bacteremia, where the risk actually lives.

When a Result Can Mislead You

Four things distort the picture more than anything else:

• Timing after illness: DNA persists for weeks. Test in that window and you can get a positive that reflects a past infection, not a current one.
• Antibiotics already started: if you began antibiotics before collecting the sample, culture may fail even when PCR stays positive, because culture needs live, growing organisms.
• Which species the panel reports: many commercial panels report C. jejuni and C. coli as a single combined result and cannot say which one you have. Broad genus-level assays go further and can pick up species with different or less settled clinical meaning, such as C. concisus or Candidatus Campylobacter infans. A positive genus result is not the same as a positive C. coli result.
• Sample handling: this organism is fragile. Freezing a sample before analysis can kill it, which is why culture underperforms in field studies while PCR holds up. Get the sample to the lab according to the collection instructions.

Laboratory interference is uncommon with this assay, though substances in stool can occasionally block DNA copying and affect amplification.